Cerebrospinal fluid and plasma concentrations of the inflammatory marker soluble CD27 in a large surgical population.
Health sciences
Internal medicine
Medical specialty
Medicine
Neurology
Neurosurgery
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
21 Jun 2024
21 Jun 2024
Historique:
received:
02
11
2023
revised:
08
04
2024
accepted:
16
05
2024
medline:
17
6
2024
pubmed:
17
6
2024
entrez:
17
6
2024
Statut:
epublish
Résumé
Soluble CD27 (sCD27) is a potential biomarker for diseases involving immune dysfunction. As there is currently little data on cerebrospinal fluid (CSF) sCD27 concentrations in the general population we measured CSF and plasma concentrations in 486 patients (age range 18-92 years, 57% male) undergoing spinal anesthesia for elective surgery. Across the complete cohort the median [range] sCD27 concentrations were 163 [<50 to 7474] pg/mL in CSF and 4624 [1830 to >400,000] pg/mL in plasma. Plasma sCD27, age and Qalb were the factors most strongly associated with CSF sCD27 levels. Reference sCD27 concentration intervals (central 95% of values) in a sub-group without the indication of neuropsychiatric, inflammatory or systemic disease (158 patients) were <50 pg/mL - 419 pg/mL for CSF and 2344-36422 pg/mL for plasma. These data provide preliminary reference ranges that could inform future studies of the validity of sCD27 as a biomarker for neuro- and systemic inflammatory disorders.
Identifiants
pubmed: 38883839
doi: 10.1016/j.isci.2024.110036
pii: S2589-0042(24)01261-6
pmc: PMC11179565
doi:
Types de publication
Journal Article
Langues
eng
Pagination
110036Informations de copyright
© 2024 The Authors. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare no competing interests.